| scholarly article | Q13442814 |
| P2093 | author name string | D M Lyerly | |
| T D Wilkins | |||
| S H Richardson | |||
| D E Lockwood | |||
| P2860 | cites work | Purification and characterization of toxins A and B of Clostridium difficile | Q24604972 |
| Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells | Q33623017 | ||
| Clostridium difficile and the aetiology of pseudomembranous colitis | Q34058811 | ||
| Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice | Q34426570 | ||
| Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea | Q34475487 | ||
| Production of Vascular Permeability Factor by Enterotoxigenic Escherichia coli Isolated from Man | Q34497661 | ||
| Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia | Q34708067 | ||
| Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis | Q38537810 | ||
| Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia | Q38537827 | ||
| Partial purification of a toxin found in hamsters with antibiotic-associated colitis. Reversible binding of the toxin by cholestyramine | Q39243143 | ||
| Comparison of two toxins produced by Clostridium difficile | Q40612560 | ||
| Gastrointestinal and systemic toxicity of fecal extracts from hamsters with clindmycin-induced colitis | Q40828456 | ||
| Purification and characterization of Clostridium difficile toxin | Q40877544 | ||
| Clindamycin-induced enterocolitis in hamsters | Q41039811 | ||
| Clostridium difficile in gnotobiotic mice | Q41162628 | ||
| Enterotoxin production of Yersinia enterocolitica strains. | Q41540595 | ||
| Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage | Q67251737 | ||
| Identification of Clostridium difficile as a cause of pseudomembranous colitis | Q67288099 | ||
| Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters | Q67697866 | ||
| Clinical and laboratory observations in Clostridium difficile colitis | Q71386018 | ||
| Effects of Clostridium difficile Toxin on Tissue-Cultured Cells | Q72847346 | ||
| An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane | Q73363678 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | 1147-1150 | |
| P577 | publication date | 1982-03-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Biological activities of toxins A and B of Clostridium difficile | |
| P478 | volume | 35 |
| Q57445886 | Absence of intestinal secretion on supernatants from macrophages stimulated with Clostridium difficile toxin B on rabbit ileum |
| Q35710147 | Active and passive immunization against Clostridium difficile diarrhea and colitis |
| Q48356396 | Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy |
| Q35122389 | Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. |
| Q41875678 | Association between production of toxins A and B and types of Clostridium difficile |
| Q35117848 | Asymptomatic neonatal colonisation by Clostridium difficile |
| Q36961946 | Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters |
| Q77349069 | Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat |
| Q37025852 | Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc |
| Q36970376 | Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile |
| Q37144615 | Characterization of cross-reactive proteins detected by Culturette Brand Rapid Latex Test for Clostridium difficile |
| Q40638584 | Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping |
| Q37011926 | Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies |
| Q35370377 | Clostridial enteric diseases of domestic animals |
| Q37419825 | Clostridium difficile 30 years on: what has, or has not, changed and why? |
| Q27339318 | Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism |
| Q41193374 | Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms |
| Q70302615 | Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit |
| Q71298919 | Clostridium difficile and its toxins |
| Q34003957 | Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice |
| Q40763960 | Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant. |
| Q43220463 | Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage |
| Q30452844 | Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes. |
| Q24561503 | Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers |
| Q35589374 | Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes |
| Q67732507 | Clostridium difficile toxin B disrupts the barrier function of T84 monolayers |
| Q35619086 | Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells. |
| Q34214675 | Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro |
| Q40159699 | Clostridium difficile toxins A and B inhibit human immune response in vitro |
| Q36640296 | Clostridium difficile: clinical disease and diagnosis |
| Q24617347 | Clostridium difficile: its disease and toxins |
| Q40144039 | Comparison of culture, cytotoxin assay and two EIA tests with clinical diagnosis of Clostridium difficile-associated diarrhea |
| Q40178561 | Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. |
| Q36959185 | Construction and expression of the complete Clostridium difficile toxin A gene in Escherichia coli |
| Q55279053 | Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity. |
| Q68875632 | Detection of Clostridium difficile Toxin A by immunoblotting |
| Q37246483 | Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease |
| Q40160408 | Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells |
| Q30446178 | Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis |
| Q36492515 | Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon |
| Q37021640 | Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice |
| Q52653036 | Effects of Clostridium difficile toxin A on K562/A02 cell proliferation, apoptosis and multi-drug resistance. |
| Q24651060 | Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro |
| Q37074797 | Effects of Clostridium difficile toxins given intragastrically to animals |
| Q40673310 | Effects of anti-inflammatory drugs on fever and neutrophilia induced by Clostridium difficile toxin B. |
| Q36441243 | Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. |
| Q36996688 | Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one |
| Q30449794 | Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion |
| Q42146936 | Enterotoxic activity of Klebsiella oxytoca cytotoxin in rabbit intestinal loops. |
| Q34601691 | Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain |
| Q40216280 | Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile |
| Q24652980 | Enzyme-linked immunosorbent assay for Clostridium difficile toxin A |
| Q44737713 | Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore |
| Q39867842 | Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages |
| Q68046188 | Evaluation of an enzyme immunoassay for detection of Clostridium difficile toxin A |
| Q37305492 | Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens |
| Q30850682 | Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium |
| Q67667110 | Fast purification of Clostridium sordellii cytotoxin |
| Q52581850 | Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice. |
| Q42142150 | Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B. |
| Q24676013 | Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection |
| Q46911443 | Ileal smooth muscle motility depression on rabbit induced by toxin A from Clostridium difficile |
| Q36630071 | Immunogenicity and protective efficacy of Clostridium difficile spore proteins |
| Q33866797 | Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. |
| Q61806523 | Impact of CodY protein on metabolism, sporulation and virulence in Clostridioides difficile ribotype 027 |
| Q89551586 | Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection |
| Q40155029 | Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization |
| Q39748439 | International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants |
| Q35841034 | Intravenous immunoglobulin therapy for severe Clostridium difficile colitis |
| Q39606562 | Laboratory diagnosis of Clostridium difficile-associated diarrhoea |
| Q36946424 | Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A |
| Q67919635 | Lower Intestinal Bleeding in the Elderly |
| Q36657238 | Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria |
| Q37274931 | Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A |
| Q40012214 | Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination |
| Q24607564 | Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit |
| Q30434555 | New developments in enteric bacterial toxins |
| Q39663975 | Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples |
| Q37067252 | Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. |
| Q36965686 | Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate |
| Q39664770 | Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France |
| Q35044119 | Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. |
| Q36347003 | Pseudomembranous colitis in Clostridium difficile-monoassociated rats. |
| Q37004400 | Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). |
| Q33602753 | Purification and characterization of alpha-toxin produced by Clostridium novyi type A |
| Q36942789 | Purification and characterization of an enterotoxin from Bacteroides fragilis |
| Q24604972 | Purification and characterization of toxins A and B of Clostridium difficile |
| Q37021851 | Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin |
| Q54566485 | Role of tumor necrosis factor and nitric oxide in the cytotoxic effects of Clostridium difficile toxin A and toxin B on macrophages. |
| Q37098464 | Sealed adult mice: new model for enterotoxin evaluation |
| Q68199126 | Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile |
| Q33673934 | Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. |
| Q40225012 | Survey of the extrachromosomal gene pool of Clostridium difficile |
| Q35131944 | Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. |
| Q26775010 | The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins |
| Q37954308 | The enterotoxicity of Clostridium difficile toxins |
| Q73519442 | The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B |
| Q24562382 | The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile |
| Q49282081 | The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model |
| Q47734724 | The role of toxins in Clostridium difficile infection. |
| Q34623572 | The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection |
| Q92458052 | The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins |
| Q35872353 | Time-resolved amino acid uptake of Clostridium difficile 630Δerm and concomitant fermentation product and toxin formation |
| Q38899041 | Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile |
| Q36159563 | Toward a structural understanding of Clostridium difficile toxins A and B. |
| Q33590965 | Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease |
| Q40668497 | Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. |
| Q34880915 | Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin |
| Q40220668 | Two bacteriophages of Clostridium difficile. |
| Q37680481 | Variations in virulence and molecular biology among emerging strains of Clostridium difficile |
| Q42010469 | Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile |
Search more.